Profil
Roger Wiklund currently works as a Director at STB INN AB.
Aktive Positionen von Roger Wiklund
Unternehmen | Position | Beginn |
---|---|---|
Strandbacka Medical
Strandbacka Medical Medical SpecialtiesHealth Technology Strandbacka Medical is a Swedish company that is revolutionizing the assessment of patients with abdominal pain. The company is based in Varberg, Sweden. The company is developing a novel medical device called Perisign, which aids healthcare professionals in making a fast, objective, and correct assessment of patients with acute abdominal pain. Perisign evaluates patients within minutes and determines if they need further investigations, medical treatment, surgery, or if it is safe to go home. The device detects if the patient suffers from peritonitis, the physiological response to severe intraabdominal illness. This decreases the need for X-ray investigations and makes the subjective, manual investigation objective, increasing ER throughput. The company was founded in 2020 by Ingrid Jonsson and Andreas Jonsson. Andreas Jonsson has been the CEO since 2020. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Strandbacka Medical
Strandbacka Medical Medical SpecialtiesHealth Technology Strandbacka Medical is a Swedish company that is revolutionizing the assessment of patients with abdominal pain. The company is based in Varberg, Sweden. The company is developing a novel medical device called Perisign, which aids healthcare professionals in making a fast, objective, and correct assessment of patients with acute abdominal pain. Perisign evaluates patients within minutes and determines if they need further investigations, medical treatment, surgery, or if it is safe to go home. The device detects if the patient suffers from peritonitis, the physiological response to severe intraabdominal illness. This decreases the need for X-ray investigations and makes the subjective, manual investigation objective, increasing ER throughput. The company was founded in 2020 by Ingrid Jonsson and Andreas Jonsson. Andreas Jonsson has been the CEO since 2020. | Health Technology |